Anthem Blue Cross is collaborating with Stanford to launch the AI for Health Affiliation program, a corporate affiliates program within the Stanford Department of Computer Sciences that will fund research on how AI can improve the efficiency and value of Anthem Blue Cross and its health plans.
Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.
The FDA’s continued crackdown of the vaping and e-cigarette industry is questionable after the resignation of its commissioner Scott Gottlieb, who announced March 5 he would depart sometime in the next month.
As electronic health records (EHRs) continue to play a huge role for healthcare operators, chief information officers have new concerns and priorities to ensure success. With rising cyberattacks on protected medical information about patients, CIOs are putting more importance on cybersecurity.
Data alone can’t bring in new partnerships and build a successful healthcare operator. There has to be a story behind the data to help get new models of care off the ground, according to partners with PwC, who spoke at ACHE's Congress on Healthcare Leadership conference in Chicago.
In the midst of breakup woes that include a court fight, the failed merger between Cigna and Anthem apparently weighed heavily on the mind of Cigna’s CEO, David Cordani, before it even fell apart. According to Bloomberg, Cordani privately expressed regret he had agreed to the deal that would have left him in a reduced role.
The tension that has long simmered between providers and payers across U.S. healthcare is ripe for the easing. And the present moment may offer the best opportunity in decades for all parties to build trust where suspicion has become the default position.